NCT01595724View on ClinicalTrials.gov

Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life

CompletedOBSERVATIONAL
Enrollment

3,006

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

May 31, 2015

Conditions
Endometriosis
Interventions
DRUG

Visanne (Dienogest, BAY86-5258)

Intake of Dienogest 2mg/day to treat Endometriosis according to regular clinical practice.

Trial Locations (11)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY